瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

orifarm ab - ciklosporin - kapsel, mjuk - 50 mg - ciklosporin 50 mg aktiv substans; etanol, vattenfri hjälpämne; propylenglykol hjälpämne; glycerol 85% hjälpämne - hund

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

orifarm ab - ciklosporin - kapsel, mjuk - 100 mg - ciklosporin 100 mg aktiv substans; propylenglykol hjälpämne; makrogolglycerolhydroxistearat hjälpämne; etanol, vattenfri hjälpämne; glycerol 85% hjälpämne - hund

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

medartuum ab - ciklosporin - kapsel, mjuk - 100 mg - makrogolglycerolhydroxistearat hjälpämne; etanol, vattenfri hjälpämne; ciklosporin 100 mg aktiv substans; propylenglykol hjälpämne; glycerol 85% hjälpämne - hund

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

2care4 aps - ciklosporin - kapsel, mjuk - 100 mg - propylenglykol hjälpämne; glycerol 85% hjälpämne; makrogolglycerolhydroxistearat hjälpämne; etanol, vattenfri hjälpämne; ciklosporin 100 mg aktiv substans - hund

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

2care4 aps - ciklosporin - kapsel, mjuk - 100 mg - propylenglykol hjälpämne; ciklosporin 100 mg aktiv substans; etanol, vattenfri hjälpämne; makrogolglycerolhydroxistearat hjälpämne; glycerol 85% hjälpämne - hund

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

elanco gmbh - ciklosporin - oral lösning - 100 mg/ml - makrogolglycerolhydroxistearat hjälpämne; etanol, vattenfri hjälpämne; ciklosporin 100 mg aktiv substans; propylenglykol hjälpämne - ciklosporin - hund, katt

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

s.a. alcon-couvreur n.v. - betaxololhydroklorid; pilokarpinhydroklorid - Ögondroppar, suspension - bensalkoniumklorid hjälpämne; mannitol hjälpämne; betaxololhydroklorid 3,5 mg aktiv substans; borsyra hjälpämne; pilokarpinhydroklorid 87,5 mg aktiv substans - kombinationer

欧盟 - 瑞典文 - EMA (European Medicines Agency)

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agenter för dermatit, med undantag av kortikosteroider - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

teva b.v. - lidokain; prilokain - kräm - 25 mg/g + 25 mg/g - makrogolglycerolhydroxistearat hjälpämne; lidokain 25 mg aktiv substans; prilokain 25 mg aktiv substans - kombinationer

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

evolan pharma ab - urea - kräm - 50 mg/g - propylenglykol hjälpämne; etylparahydroxibensoat hjälpämne; cetostearylalkohol hjälpämne; metylparahydroxibensoat hjälpämne; urea 50 mg aktiv substans